Nitrous oxide

Description

Nitrous Oxide USP (UN1070) is a non-flammable gas classified as an oxidizer (5.1) with a Chemical Abstracts Service (CAS) number of 10024-97-2. This product is available by prescription only. It is distributed by ABCO Welding Supply, located in Waterford, CT, with additional distribution points in Milford, CT, and South Windsor, CT. Contact numbers for distribution are 860-442-0363 for Waterford, 203-874-9393 for Milford, and 860-528-5040 for South Windsor.

Uses and Indications

This drug is indicated for use in medical settings where Nitrous Oxide administration is deemed appropriate. It is intended for administration only by or under the supervision of a licensed practitioner who possesses experience in the use of Nitrous Oxide. The practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with Nitrous Oxide, which may render its administration contraindicated in certain situations. There are no specific teratogenic or nonteratogenic effects documented for this drug.

Dosage and Administration

Administration of Nitrous Oxide is to be conducted exclusively by or under the supervision of a licensed practitioner who possesses experience in its use and administration. The practitioner must be well-versed in the indications, effects, dosages, methods, and frequency and duration of administration, as the use of Nitrous Oxide may pose hazards or be contraindicated in certain situations.

Nitrous Oxide is administered via the respiratory route through inhalation. The active ingredient is contained in a concentration of 990 mL within a 1 L volume. It is imperative that practitioners adhere to established protocols for preparation and administration to ensure patient safety and efficacy of the treatment.

Contraindications

Administration of Nitrous Oxide is contraindicated in the following situations:

Use is restricted to licensed practitioners experienced in its administration, who are knowledgeable about its indications, effects, dosages, methods, frequency, duration, hazards, contraindications, side effects, and necessary precautions.

Nitrous Oxide should not be administered in environments where there is a risk of gas inhalation or exposure to liquid form, as it may pose hazards. Specifically, avoid contact with eyes, skin, or clothing to prevent potential injury.

Warnings and Precautions

Administration of Nitrous Oxide may pose significant risks and is contraindicated in certain situations. It is imperative that this agent be used solely by or under the supervision of a licensed practitioner who possesses expertise in its administration. The practitioner must be well-versed in the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Nitrous Oxide is classified as a high-pressure oxidizing liquid and gas, which vigorously accelerates combustion. This substance can lead to rapid suffocation and may induce anesthetic effects. Additionally, exposure to Nitrous Oxide can result in frostbite. To mitigate these risks, it is crucial to avoid inhalation of the gas and to ensure adequate ventilation during storage and use. Equipment must be specifically cleaned for oxygen use and rated for cylinder pressure. It is essential to keep oil and grease away from the gas, and to prevent liquid from contacting the eyes, skin, or clothing. The temperature of the cylinder should not exceed 52°C (125°F). Valves should be opened slowly, and closed after each use and when empty. Compliance with the Material Safety Data Sheet (MSDS) is mandatory. Practitioners should also be aware that suck-back into the cylinder may cause rupture; therefore, a back-flow preventive device must always be utilized in the piping.

In the event of an emergency, immediate action is required. If Nitrous Oxide is inhaled, the individual should be removed to fresh air. If breathing has ceased, artificial respiration should be administered. In cases where breathing is difficult, supplemental oxygen should be provided, and a physician should be contacted without delay. In instances of frostbite, prompt medical treatment is essential.

Side Effects

Administration of Nitrous Oxide may pose significant hazards and is contraindicated in certain situations. It is classified as a high-pressure oxidizing liquid and gas, which vigorously accelerates combustion, potentially leading to rapid suffocation. Additionally, it may induce anesthetic effects and can cause frostbite upon contact with skin or mucous membranes.

Patients are advised to avoid breathing the gas directly and to ensure that the environment is adequately ventilated during use. It is crucial to keep oil and grease away from the area of administration, as these substances can pose additional risks. Equipment used for Nitrous Oxide should be specifically cleaned for oxygen and rated for the appropriate cylinder pressure to prevent accidents. Care should be taken to avoid contact with liquid Nitrous Oxide in the eyes, on the skin, or on clothing. The cylinder temperature must not exceed 52°C (125°F), and valves should be opened slowly and closed after each use or when empty. It is essential to follow the guidelines outlined in the Material Safety Data Sheet (MSDS) and to utilize back-flow preventive devices in the piping to avoid potential rupture from suck-back into the cylinder.

In the event of inhalation, patients should be removed to fresh air immediately. If the patient is not breathing, artificial respiration should be administered, and if breathing is difficult, supplemental oxygen should be provided. Medical assistance should be sought promptly. In cases of frostbite, immediate medical treatment is necessary.

Drug Interactions

There are currently no specific drug interactions identified for the medication. Additionally, no interactions with laboratory tests have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time. It is advisable for healthcare professionals to remain vigilant and consult updated resources as new data may emerge.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Administration of Nitrous Oxide may pose hazards or be contraindicated in pediatric patients. It is essential that it be used only by or under the supervision of a licensed practitioner experienced in its administration, particularly within pediatric populations.

Safety and efficacy in children have not been established, necessitating special precautions during administration. Care should be taken due to the potential anesthetic effects and the risks associated with rapid suffocation in this demographic.

Geriatric Use

There is no specific information regarding the use of Nitrous Oxide in geriatric patients, including age considerations, dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when administering this agent to elderly patients, as individual responses may vary. Monitoring for potential adverse effects is advisable, given the lack of targeted studies in this population.

Pregnancy

Administration of Nitrous Oxide may pose risks during pregnancy and is considered hazardous or contraindicated for pregnant patients. Due to the potential for adverse effects on fetal outcomes, it is essential that Nitrous Oxide is used only by or under the supervision of a licensed practitioner who has experience in its administration. Healthcare professionals should exercise caution and evaluate the risks versus benefits when considering the use of Nitrous Oxide in pregnant patients.

Lactation

There is no information available regarding the use of Nitrous Oxide in nursing mothers or its effects on lactation. Consequently, the safety and excretion of Nitrous Oxide in breast milk, as well as its potential effects on breastfed infants, remain undetermined. Healthcare professionals should exercise caution and consider the lack of data when advising lactating mothers on the use of this agent.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the drug insert for Nitrous Oxide. Healthcare professionals should exercise caution and consider the lack of data when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrous Oxide. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this patient population. It is recommended that healthcare providers exercise clinical judgment when considering the use of Nitrous Oxide in patients with compromised liver function, as individual patient factors may influence treatment decisions.

Overdosage

Overdosage of Nitrous Oxide can result in significant anesthetic effects, which may pose serious risks to the individual. It is crucial for healthcare professionals to recognize the potential hazards associated with the administration of Nitrous Oxide, as it may be contraindicated in certain situations.

In the event of an overdosage, immediate action is required. The first step is to remove the affected individual to an area with fresh air to mitigate the effects of the gas. If the individual is not breathing, it is imperative to provide artificial respiration promptly. Should the individual experience difficulty in breathing, supplemental oxygen should be administered to ensure adequate oxygenation.

Furthermore, it is essential to seek medical assistance by calling a physician for further evaluation and management of the situation. Prompt intervention can significantly improve outcomes in cases of Nitrous Oxide overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No specific postmarketing experience details are available. As such, there are no additional adverse events or rare case reports to summarize at this time.

Patient Counseling

Healthcare providers should advise patients that the administration of Nitrous Oxide may pose hazards or be contraindicated. It is essential that this substance is used only by or under the supervision of a licensed practitioner who possesses experience in its administration. The practitioner should be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Providers must communicate the following warning to patients: Nitrous Oxide is a high-pressure oxidizing liquid and gas that vigorously accelerates combustion, can cause rapid suffocation, and may induce anesthetic effects. Additionally, it has the potential to cause frostbite.

Patients should be instructed to avoid breathing the gas and to ensure adequate ventilation during use. They should be cautioned to keep oil and grease away from the area of use and to utilize equipment that has been cleaned for oxygen and is rated for cylinder pressure. It is critical to avoid contact with liquid Nitrous Oxide in the eyes, on the skin, or on clothing. The cylinder temperature must not exceed 52°C (125°F), and the valve should be opened slowly. Patients should be reminded to close the valve after each use and when the cylinder is empty, and to follow the guidelines outlined in the Material Safety Data Sheet (MSDS).

Healthcare providers should also inform patients about the risk of suck-back into the cylinder, which may lead to rupture. It is imperative to always use a back-flow preventive device in the piping.

In the event of an emergency, providers should instruct patients on first aid measures: if Nitrous Oxide is inhaled, they should be removed to fresh air. If the patient is not breathing, artificial respiration should be administered. If breathing is difficult, oxygen should be provided, and a physician should be contacted. In cases of frostbite, immediate medical treatment is necessary.

Storage and Handling

The product is supplied in cylinders that must be handled with care to ensure safety and efficacy. The maximum allowable temperature for storage and use of the cylinders is 52°C (125°F). It is essential to maintain adequate ventilation in the area where the cylinders are stored and used to prevent the accumulation of potentially hazardous gases.

To ensure safe handling, it is critical to keep oil and grease away from the cylinders. Equipment used in conjunction with the cylinders should be thoroughly cleaned for oxygen service and rated for the appropriate cylinder pressure.

When operating the cylinder, the valve should be opened slowly to prevent sudden pressure changes. After each use, and when the cylinder is empty, the valve must be closed securely. Additionally, a back-flow preventive device should always be utilized in the piping to avoid any reverse flow of gases.

Care should be taken to prevent any liquid from coming into contact with the eyes, skin, or clothing during handling.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide as submitted by ABCO Welding and Industrial Supply Inc.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)